The Lancet - один из наиболее известных, старых и самых авторитетных общих журналов по медицине. The Lancet - независимый международный медицинский журнал общего профиля, основанный в 1823 году Томасом Вакли. С момента своего первого еженедельного выпуска (5 октября 1823 г.) журнал стремился сделать науку широко доступной, чтобы медицина могла служить обществу и преобразовывать его, а также положительно влиять на жизнь людей.

Новый выпуск журнала "The Lancet" включает статьи:

EDITORIAL

• Responding to Ebola: a test

COMMENT

• The PHEIC for Ebola disease caused by Bundibugyo virus: an inflection point for solidarity and health equity
• Targeting CD40 with dapirolizumab pegol: a new treatment for systemic lupus erythematosus
• Challenges in mitigating weight regain with incretin-based therapy
• Microvascular dysfunction in atherosclerotic coronary disease

WORLD REPORT

• Rik Peeperkorn: health and humanitarianism in Gaza
• Hypertension control: a South Korean success story

PERSPECTIVES

• Donald Warne: redressing inequities in Indigenous health
• Still dying: adverse birth outcomes among Black people in the USA
• The way forward
• Ethical shunts: an old woman in an Italian emergency department

OBITUARY

• Harold Ellis

CORRESPONDENCE

• Cruise ship hantavirus outbreak in remote island communities
• Hantavirus outbreak on a cruise ship in the South Atlantic
• The death of the assisted dying bill is an opportunity
• Failure to introduce alcohol health-warning labels in Ireland
• Time to integrate pets in One Health surveillance
• Minocycline for acute ischaemic stroke: limitations of the EMPHASIS trial
• Minocycline for acute ischaemic stroke: limitations of the EMPHASIS trial – Authors’ reply

DEPARTMENT OF ERROR

• Department of Error

ARTICLES

• Efficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial
• Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial
• Coronary microvascular dysfunction and cardiovascular outcomes (Multicenter FLOW-CMD Registry): a prospective, multicentre cohort study in South Korea

HEALTH POLICY

• Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process

VIEWPOINT

• Who's really in the loop? Rethinking oversight in AI-assisted health care

Медицинские специалисты Кузбасса могут отправить запрос на 📧medlibchz2025@yandex.ru с пометкой «Хочу читать The Lancet» и получать на свою почту еженедельно свежий выпуск журнала.